Author:
Wang Ying,Tang Chengyuan,Cai Juan,Chen Guochun,Zhang Dongshan,Zhang Zhuohua,Dong Zheng
Funder
National Natural Science Foundation of China
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference48 articles.
1. Wang, D. & Lippard, S. J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4, 307–320 (2005).
2. Rancoule, C. et al. 50th anniversary of cisplatin. Bull. Cancer 104, 167–176 (2017).
3. Miller, R. P., Tadagavadi, R. K., Ramesh, G. & Reeves, W. B. Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2, (2490–2518 (2010).
4. Pabla, N. et al. Inhibition of PKCdelta reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer. J. Clin. Invest. 121, 2709–2722 (2011).
5. Ozkok, A. & Edelstein, C. L. Pathophysiology of cisplatin-induced acute kidney injury. Biomed. Res. Int. 2014, 967826 (2014).
Cited by
141 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献